Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted predominantly by intestinal enteroendocrine L cells in response to nutrient ingestion. By enhancing insulin secretion, delaying ...

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.

Rates of metabolic and bariatric surgeries (MBS) rose by almost 15% in teenagers in the US between 2021 and 2023, despite falling in adults, new research has found. The cross-sectional analysis, ...

Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...

New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 diabetes and chronic weight management ...

A new Irish health clinic is set to make ‘fat jabs’ more accessible to those battling obesity. But the top medic leading the ...

Medicine, lifestyle changes, and surgery can return glucose levels to normal or nearly normal in some type 2 diabetes ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.